Crown Bioscience has launched an e-commerce platform to support the commercialisation of its Life Science products. The company is a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research.
The launch follows the recent expansion of CrownBio's Life Science division and answers the need to accommodate an increasing demand for the Company's products.
CrownBio's clients will now be able to purchase hundreds of products online across a portfolio consisting of: antibodies for in vivo and in vitro studies, recombinant proteins and cell lines, immune checkpoint antibodies, and tumor tissue microarrays.
This digital tool facilitates and accelerates clients' ordering, enabling them to create online accounts to track the history of their previous orders, save and share quotations for pending approval, and conveniently process transactions.
Laurie Heilmann, SVP of Global Strategy, Marketing and Business Development, said: “I am pleased we could successfully pivot CrownBio digital engagement efforts with the development of the e-commerce platform, which will ensure a client friendly, efficient experience to purchasing our products.”
